Volume 13 Issue 11, November 2016

Volume 13 Issue 11

Cover image supplied by S. Ferreira-Gonzalez and S.J. Forbes, MRC Centre for Regenerative Medicine, Edinburgh, UK, who are funded by MRC and Principal’s Career Development Edinburgh University grants. Immunofluorescence image of ductular reaction in the liver. Tissue was stained to show marker of biliary differentiation keratin 19 (rat anti-troma III) and red fluorescent protein (rabbit anti-RFP). Nuclei were stained by DAPI.

Research Highlights

News and Views

  • News & Views |

    The first phase of chronic hepatitis B, the immune tolerance phase, is traditionally considered to be a quiescent stage of disease. Emerging data now suggests the contrary, with immunological, pathological and virological evidence supporting an underlying active disease, signifying the need to consider earlier treatment commencement.

    • Wai-Kay Seto
    •  & Man-Fung Yuen
  • News & Views |

    A new study has advanced our knowledge on the pathogenesis of noncoeliac wheat sensitivity (NCWS), implicating the activation of innate immunity markers and immunological mechanisms at the basis of NCWS. However, limitations in the design of studies performed in this field will need addressing to help identify the root cause of NCWS.

    • Antonio Carroccio
  • News & Views |

    The gastrointestinal safety of incretin-based therapies is controversial. Two new studies find no effect of GLP-1 receptor agonists on acute pancreatitis risk, but increased risk of bile duct and gallbladder disease. However, no retrospective epidemiological studies can provide definitive answers, and nausea, vomiting and diarrhoea remain the most clinically relevant adverse effects of these drugs, compromising long-term adherence.

    • Juris J. Meier
    •  & Julio Rosenstock

Reviews